Hypha Labs, Inc. in brief
Hypha Labs, Inc. is a listed company in the Diagnostics and Research industry, based in Nevada, USA. Its last known market value was $2 M (January 2022); there is no current figure. Its shares trade under the symbol FUNI (OTC Markets Group).
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
Market cap history
Not enough history yet.
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- —
- Operating margin
- —
- Return on equity
- —
- Liabilities / assets
- 612.2%
- Revenue growth
- +8.0%
- R&D / revenue
- 700.0%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | — | — | $-3M | $-3M | — |
| Sep 2024 | — | — | $-2M | $-1M | — |
| Sep 2023 | — | — | $-0M | $0M | — |
| Sep 2022 | $3M | +8.0% | $-1M | $-2M | -76.3% |
| Sep 2021 | $3M | -2.7% | $-1M | $-1M | -27.6% |
| Sep 2020 | $3M | +0.8% | $-2M | $-2M | -89.9% |
| Sep 2019 | $3M | -10.2% | $-2M | $-2M | -71.0% |
| Sep 2018 | $3M | — | $-2M | $-2M | -58.1% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Sep 2025 | $-0M | $0M | $-0M | $-0.02 | — |
| Sep 2024 | $-1M | $0M | $-1M | $-0.01 | — |
| Sep 2023 | $0M | — | — | $0.00 | — |
| Sep 2022 | $-0M | $0M | $-0M | $-0.03 | — |
| Sep 2021 | $-0M | $0M | $-0M | $-0.01 | — |
| Sep 2020 | $-1M | $0M | $-1M | $-0.04 | — |
| Sep 2019 | $-1M | $0M | $-1M | $-0.04 | — |
| Sep 2018 | $-0M | $0M | $-0M | $-0.04 | — |
Quarterly results
Latest quarter to Jun 2026: revenue —, net income $-0M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.
Annual results
- Revenue
- —
- Operating income
- $-3 M
- Net income
- $-3 M
For year ending September-2025 · source: SEC filing
Balance sheet
- Total assets
- $0 M
- Total liabilities
- $3 M
- Total equity
- $-2 M
As of September-2025
Markets and events: Hypha Labs, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Stock splits: 1-for-10 reverse split
Hypha Labs, Inc. scorecard#
Passes 0 of the 7 checks that could be worked out. Fiscal year 2025.
Valuationnot known
Growth0 of 2
Profitability0 of 2
Financial health0 of 2
Shareholder returns0 of 1
Worked out from the statements as filed (sec), the medians of Diagnostics and Research, the 10-year Treasury yield of Nov 20, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Hypha Labs, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Sep 30, 2025 | FY 2024to Sep 30, 2024 | FY 2023to Sep 30, 2023 | FY 2022to Sep 30, 2022 | FY 2021to Sep 30, 2021 | FY 2020to Sep 30, 2020 | FY 2019to Sep 30, 2019 | FY 2018to Sep 30, 2018 | FY 2017to Sep 30, 2017 | FY 2016to Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | — | — | — | 2,700 | 2,504 | 2,574 | 2,553 | 2,840 | 1,898 | 819 | |
| Cost of revenue | — | — | — | 1,634 | 1,789 | 1,779 | 1,713 | 2,070 | 904 | 380 | |
| Gross profit | — | — | — | 1,066 | 715 | 796 | 840 | 770 | 994 | 439 | |
| General and administrative | 1,417 | 944 | 103 | 496r | 934 | 1,483 | 1,674 | 2,057r | 1,258 | 1,261r | |
| Operating expenses | 3,001 | 1,827 | 437 | 1,150r | 1,488 | 2,988 | 2,683 | 2,529 | 2,291r | 3,321 | |
| Operating income | −3,001 | −1,827 | −437 | −1,150r | −772 | −2,192 | −1,843 | −1,759 | −1,297r | −2,882 | |
| Interest expense and finance costs | 106 | 202 | 364 | 245r | 145 | 148 | 66 | — | — | — | |
| Net interest income | — | — | — | 63 | 0.9r | — | — | — | — | — | |
| Other non-operating income (expense) | −100 | 471 | −244 | −1,027r | 86 | −117 | 38 | 105 | 232r | −817 | |
| Income before tax | −3,102 | −1,356 | −682 | — | — | — | — | — | — | — | |
| Income tax | — | 14 | — | — | — | — | — | — | — | — | |
| Income from continuing operations | −3,102 | −1,371 | −682 | −2,178 | — | — | — | — | — | — | |
| Income from discontinued operations | — | 585 | 928 | 120 | — | — | — | — | — | — | |
| Minority interests' share of net income | — | — | — | — | — | — | — | — | — | 3,699 | |
| Net income attributable to shareholders | −3,102 | −785 | 247 | −2,057 | −687 | −2,309 | −1,805 | −1,654 | −1,065 | −3,699 | |
| Earnings per share, basic | -0.02 | -0.01 | 0.00 | -0.03 | -0.01 | -0.04 | -0.04 | -0.04 | -0.04 | -0.20 | |
| Earnings per share, diluted | -0.02 | -0.01 | 0.00 | -0.03 | -0.01 | -0.04 | -0.04 | -0.04 | -0.04 | -0.20 | |
| Shares, weighted average (basic) | 135 | 101 | 84 | 74 | 66 | — | — | — | — | — | |
| Shares, weighted average (diluted) | 135 | 101 | 84 | 74 | 66 | 53 | 46 | 39 | 29 | 18 | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 38 | 91 | 271 | 56 | 296 | 83 | 324 | 176 | 178 | 135 | |
| Receivables | — | — | — | 335 | 215 | 242 | 179 | 168 | 267 | 98 | |
| Other current assets | 27 | 289 | 8.6 | 13r | 60r | 5.5 | 75 | 73 | — | — | |
| Current assets | 321 | 410 | 766 | 562 | 827 | 397 | 629 | 442 | 544 | 298 | |
| Property, plant and equipment | 63 | 27 | — | 55r | 647 | 885 | 727 | 957 | 1,027 | 1,140 | |
| Right-of-use (leased) assets | 26 | 57 | — | 317 | 414 | 506 | — | — | — | — | |
| Goodwill | — | — | — | — | — | 593 | — | — | — | — | |
| Non-current assets | 89 | 84 | 644 | 778 | 1,061 | 1,391 | — | — | — | — | |
| Total assets | 409 | 494 | 1,409 | 1,340 | 1,888 | 1,788 | 1,356 | 1,399 | 1,571 | 1,447 | |
| Accounts payable | 473 | 86 | 122 | 201r | 371 | 388 | 137 | 326 | 122 | 158 | |
| Current liabilities | 1,119r | 1,394 | 3,122 | 2,954 | 2,014 | 773 | 471 | 385 | 164 | 212 | |
| Lease liabilities (non-current) | — | 27 | — | 230 | 330 | 424 | — | — | — | — | |
| Non-current liabilities | — | 27 | 159 | 795 | 927 | 2,105 | 459 | — | — | — | |
| Total liabilities | 2,512 | 1,420 | 3,281 | 3,749 | 2,941 | 2,878 | 930 | 385 | 164 | 212 | |
| Retained earnings | −23,649 | −20,547 | −19,762 | −20,009 | −17,952 | −17,265 | −14,956 | −13,150 | −11,497 | −10,432 | |
| Shareholders' equity | −2,437 | −1,260 | −2,205 | −2,743 | −1,053 | −1,089 | 426 | 1,015 | 1,407 | 1,235 | |
| Total equity | — | — | — | — | — | — | — | — | 1,407 | 1,235 | |
| Total liabilities and equity | 409 | 494 | 1,409 | 1,340 | 1,888 | 1,788 | 1,356 | 1,399 | 1,571 | 1,447 | |
| Shares outstanding | 147 | 123 | 87 | 75 | 71 | 58 | 48 | 42 | 35 | 22 | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | — | — | — | 204 | 292 | 323 | 261 | 277 | 254 | 245 | |
| Share-based compensation | 1,850 | 734 | 59 | 566 | 404 | 212 | 334 | 453 | 246 | 295 | |
| Cash from operating activities | −380 | −1,034 | 113 | −185 | −136 | −672 | −1,042 | −163 | −377 | −734 | |
| Capital expenditure | −33 | −28 | — | −18 | −56 | −141 | −45 | −207 | −141 | −14 | |
| Cash from investing activities | −33 | 2,146 | 263 | −660 | −286 | −341 | −135 | −207 | −141 | −72 | |
| Shares issued | 76 | — | — | 56 | 20 | 57 | 625 | 369 | 561 | 460 | |
| Cash from financing activities | 360 | −1,292 | −161 | 605 | 635 | 772 | 1,325 | 369 | 561 | 460 | |
| Change in cash | −53 | −180 | 215 | −240 | 213 | −241 | 148 | −2.2 | 43 | −346 | |
| Report | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
As of Jun 30, 2026
Acquisitions and funding#
1 acquisitions
Businesses it acquired
| Acquired | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|
| VSSL Enterprises Ltd | Mar 2020 | Mar 2020 | — | — | Annual report |
Private share sales · funding history
How Hypha Labs, Inc. compares in Diagnostics and Research
- Revenue growth8.0% · higher than 58% of 90
Peer comparison · Diagnostics and Research
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Hypha Labs, Inc.🇺🇸 | $2 M | — | — | +8.0% |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
| Danaher Corporation🇺🇸 | $166.7 B | 38.5× | 16.9% | +2.9% |
| WuXi AppTec Co., Ltd.🇨🇳 | $70.4 B | 25.4× | 42.1% | — |
| Natera, Inc.🇺🇸 | $58.7 B | — | -5.7% | +35.9% |
| Siemens Healthineers AG🇩🇪 | $52.8 B | 22.9× | 8.7% | — |
| Lonza Group AG🇨🇭 | $51.9 B | — | -4.2% | — |
| Agilent Technologies, Inc.🇺🇸 | $48.8 B | 33.9× | 19.5% | +6.7% |
| IQVIA Holdings Inc.🇺🇸 | $45.1 B | 32.4× | 8.1% | +5.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Thermo Fisher Scientific Inc.$253.8 B
- Danaher Corporation$166.7 B
- WuXi AppTec Co., Ltd.$70.4 B
- Natera, Inc.$58.7 B
- Siemens Healthineers AG$52.8 B
- Lonza Group AG$51.9 B
How current the figures are
- Market cap:
- Jan 7, 2022 (last known)
- Annual results:
- For year ending September-2025
- Balance sheet:
- As of September-2025
- Profile updated:
- Nov 22, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Hypha Labs, Inc.? Verify and update this profile — free
Show Hypha Labs, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.